| (S)-nicotine | increases expression | ISO | RGD:1320978 | 6480464 | Nicotine results in increased expression of UGP2 mRNA | CTD | PMID:18247414 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of UGP2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UGP2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UGP2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of UGP2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1310210 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UGP2 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UGP2 mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UGP2 mRNA | CTD | PMID:19465110 |
| 2-methylcholine | affects expression | ISO | RGD:1320978 | 6480464 | beta-methylcholine affects the expression of UGP2 mRNA | CTD | PMID:21179406 |
| 2-naphthylamine | increases expression | ISO | RGD:1320978 | 6480464 | 2-Naphthylamine results in increased expression of UGP2 mRNA | CTD | PMID:18247414 |
| 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of UGP2 mRNA | CTD | PMID:18648102 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1320978 | 6480464 | decitabine inhibits the reaction [Smoke results in decreased expression of UGP2 mRNA] | CTD | PMID:21095227 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of UGP2 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:1320978 | 6480464 | Benzo(a)pyrene results in increased expression of UGP2 mRNA | CTD | PMID:18247414 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of UGP2 mRNA | CTD | PMID:19770486 |
| bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of UGP2 mRNA | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of UGP2 mRNA] | CTD | PMID:19850644 |
| clofibrate | decreases expression | ISO | RGD:1310210 | 6480464 | Clofibrate results in decreased expression of UGP2 protein | CTD | PMID:16470657 |
| clofibric acid | affects expression | ISO | RGD:1310210 | 6480464 | Clofibric Acid affects the expression of UGP2 mRNA | CTD | PMID:17602206 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1320978 | 6480464 | Copper Sulfate results in decreased expression of UGP2 mRNA | CTD | PMID:19549813 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of UGP2 mRNA | CTD | PMID:19770486 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of UGP2 mRNA | CTD | PMID:21266533 |
| dichlorvos | decreases activity | ISO | RGD:1310210 | 6480464 | Dichlorvos results in decreased activity of UGP2 protein | CTD | PMID:222008 |
| ellagic acid | decreases expression | ISO | RGD:1320978 | 6480464 | Ellagic Acid results in decreased expression of UGP2 mRNA | CTD | PMID:12002526 |
| microcystin-LR | increases expression | EXP | | 6480464 | cyanoginosin LR results in increased expression of UGP2 mRNA | CTD | PMID:17654400 |
| N-methylformamide | increases expression | EXP | | 6480464 | methylformamide analog results in increased expression of UGP2 mRNA; more ... | CTD | PMID:17040096 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1310210 | 6480464 | [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of UGP2 protein | CTD | PMID:20935162 |
| paracetamol | decreases expression | ISO | RGD:1320978 | 6480464 | Acetaminophen results in decreased expression of UGP2 mRNA | CTD | PMID:21420995 |
| phenobarbital | multiple interactions | ISO | RGD:1310210 | 6480464 | [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of UGP2 protein | CTD | PMID:20935162 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of UGP2 mRNA | CTD | PMID:19710929 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of UGP2 mRNA | CTD | PMID:18445702 PMID:20813756 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of UGP2 mRNA | CTD | PMID:20813756 PMID:18445702 |
| quercetin | decreases expression | ISO | RGD:1320978 | 6480464 | Quercetin results in decreased expression of UGP2 mRNA | CTD | PMID:21632981 |
| resveratrol | decreases expression | ISO | RGD:1320978 | 6480464 | resveratrol results in decreased expression of UGP2 mRNA | CTD | PMID:12002526 |
| rosiglitazone | decreases expression | ISO | RGD:1310210 | 6480464 | rosiglitazone results in decreased expression of UGP2 mRNA | CTD | PMID:19211718 |
| rosiglitazone | increases expression | ISO | RGD:1310210 | 6480464 | rosiglitazone results in increased expression of UGP2 mRNA | CTD | PMID:19397913 PMID:19201733 |
| rosiglitazone | increases expression | ISO | RGD:1310210 | 6480464 | rosiglitazone results in increased expression of UGP2 mRNA | CTD | PMID:19201733 PMID:19397913 |
| rosiglitazone | increases expression | ISO | RGD:1310210 | 6480464 | rosiglitazone results in increased expression of UGP2 mRNA | CTD | PMID:19397913 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of UGP2 mRNA | CTD | PMID:17484886 |
| trans-resveratrol | decreases expression | ISO | RGD:1320978 | 6480464 | resveratrol results in decreased expression of UGP2 mRNA | CTD | PMID:12002526 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of UGP2 mRNA | CTD | PMID:17963808 |
| vancomycin | increases expression | EXP | | 6480464 | Vancomycin results in increased expression of UGP2 mRNA | CTD | PMID:18930951 |
| vanillin | increases expression | ISO | RGD:1320978 | 6480464 | vanillin results in increased expression of UGP2 mRNA | CTD | PMID:17178418 |